501Y.V2 immunity A preliminary study conducted by KRISP showed people previously infected with the new variant are immune from reinfection and possibly other circulating variants. The study involved a small number of people and is yet to be submitted for evaluation by the scientific community. Scientists said the plasma collected from people infected with the variant had “good neutralising activity”, including against “first wave” viruses and potentially other variants of concern. It shows that the immune response to the new variant is as potent was that seen in people infected with the old variant.— NICD (@nicd_sa) March 3, 2021 Immunity does not mean no vaccination